Octa-Cationic Porphyrin-Functionalized Biocompatible Nanocomposite: A Promising Candidate for Enhanced Combinatorial Photodynamic and Photothermal Tumor Therapy.

IF 6.8 1区 医学 Q1 CHEMISTRY, MEDICINAL
Journal of Medicinal Chemistry Pub Date : 2025-02-13 Epub Date: 2025-01-26 DOI:10.1021/acs.jmedchem.4c02584
Chang-Hao Jiang, Yong-Hui Li, Yue Yuan, Chen-Yu Wang, Jun-Qing Chu, Gui-Mei Han, De-Ming Kong, Qi-Liang Cai, Li-Na Zhu
{"title":"Octa-Cationic Porphyrin-Functionalized Biocompatible Nanocomposite: A Promising Candidate for Enhanced Combinatorial Photodynamic and Photothermal Tumor Therapy.","authors":"Chang-Hao Jiang, Yong-Hui Li, Yue Yuan, Chen-Yu Wang, Jun-Qing Chu, Gui-Mei Han, De-Ming Kong, Qi-Liang Cai, Li-Na Zhu","doi":"10.1021/acs.jmedchem.4c02584","DOIUrl":null,"url":null,"abstract":"<p><p>The integration of photodynamic therapy (PDT) and photothermal therapy (PTT) offers a promising strategy for enhancing phototherapy efficiency. Herein, we present a dual-functional, biocompatible nanocomposite system for combination PDT/PTT therapy. The system utilizes a highly biocompatible nanoparticle assembled by an amphiphilic short peptide with the assistance of Zn<sup>2+</sup> as a carrier. The photothermal convertor is loaded within the nanoparticle, while a cationic porphyrin photosensitizer is assembled on the surface. The water-soluble cationic porphyrin (M<sub>8</sub>PzEOPP), designed with eight positive charges, provides a strong electrostatic interaction for stable assembly on the nanocomposite surface. This location-independent assembly effectively maintains the optical characteristics of both the photosensitizer and the photothermal convertor, endowing the nanocomposite with effective photodynamic and photothermal properties. The nanocomposite exhibits excellent tumor-targeting accumulation behavior, low dark toxicity, robust extracellular biostability, and high cell internalization efficiency. Its enhanced performance in combinatorial therapy is demonstrated through both in vitro and in vivo experiments.</p>","PeriodicalId":46,"journal":{"name":"Journal of Medicinal Chemistry","volume":" ","pages":"3409-3419"},"PeriodicalIF":6.8000,"publicationDate":"2025-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1021/acs.jmedchem.4c02584","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/26 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

The integration of photodynamic therapy (PDT) and photothermal therapy (PTT) offers a promising strategy for enhancing phototherapy efficiency. Herein, we present a dual-functional, biocompatible nanocomposite system for combination PDT/PTT therapy. The system utilizes a highly biocompatible nanoparticle assembled by an amphiphilic short peptide with the assistance of Zn2+ as a carrier. The photothermal convertor is loaded within the nanoparticle, while a cationic porphyrin photosensitizer is assembled on the surface. The water-soluble cationic porphyrin (M8PzEOPP), designed with eight positive charges, provides a strong electrostatic interaction for stable assembly on the nanocomposite surface. This location-independent assembly effectively maintains the optical characteristics of both the photosensitizer and the photothermal convertor, endowing the nanocomposite with effective photodynamic and photothermal properties. The nanocomposite exhibits excellent tumor-targeting accumulation behavior, low dark toxicity, robust extracellular biostability, and high cell internalization efficiency. Its enhanced performance in combinatorial therapy is demonstrated through both in vitro and in vivo experiments.

Abstract Image

求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry 医学-医药化学
CiteScore
4.00
自引率
11.00%
发文量
804
审稿时长
1.9 months
期刊介绍: The Journal of Medicinal Chemistry is a prestigious biweekly peer-reviewed publication that focuses on the multifaceted field of medicinal chemistry. Since its inception in 1959 as the Journal of Medicinal and Pharmaceutical Chemistry, it has evolved to become a cornerstone in the dissemination of research findings related to the design, synthesis, and development of therapeutic agents. The Journal of Medicinal Chemistry is recognized for its significant impact in the scientific community, as evidenced by its 2022 impact factor of 7.3. This metric reflects the journal's influence and the importance of its content in shaping the future of drug discovery and development. The journal serves as a vital resource for chemists, pharmacologists, and other researchers interested in the molecular mechanisms of drug action and the optimization of therapeutic compounds.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信